Fox Business: 'Zombie stocks' exacerbating the IPO drought

EquityZen

|

August 29, 2022

Company News

What's cooling the IPO market? Hear thoughts from EquityZen's Phil Haslett on 'The Claman Countdown'.

Related Posts

Company News

EquityZen | August 24, 2018

Institutional Investor: Can SoftBank Really Meet Investors' Expectations?

Institutional Investor features EquityZen's research on SoftBank's $100 billion Vision Fund in their latest piece.

Company News

EquityZen | August 13, 2018

Bloomberg: Silicon Valley’s Unicorn Elite Are Sitting on $60 Billion in Untapped Wealth

EquityZen Co-Founder Phil Haslett talks to Bloomberg about our research on unicorn founder equity valuations.

Company News

Phil Haslett | January 2, 2024

Inc.: Companies Want to Go Public, But Aren't Ready to Pull The Trigger

New Year, new IPO market? The first quarter of 2024 will be an important indictor of what's to come for the remainder...

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2023 EquityZen. All rights reserved.